Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
03/2005
03/22/2005US6869913 Pyridazin-3-one derivatives, their use and intermediates for their production
03/22/2005US6869696 Organic red electro-luminescent device including a heterocyclic emitter
03/22/2005CA2178219C Substituted morpholine derivatives and their use as therapeutic agents
03/17/2005WO2005023807A2 4 - heterobicyclyamino - substituted quinazolines and analogues therof as capsaicin - antagonists
03/17/2005WO2005023804A1 Peptidyl heterocyclic ketone derivatives and preparation processes
03/17/2005WO2005023803A1 Phosphoric acid salt of 5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl] methyl]- 2,4-thiazolidinedione
03/17/2005WO2005023777A1 Ppar-activating compound and pharmaceutical composition containing same
03/17/2005WO2005023773A1 Process for the preparation of substituted aryl pyrazoles
03/17/2005WO2005023251A1 N3 alkylated benzimidazole derivatives as mek inhibitors
03/17/2005WO2005023247A1 Compounds and methods
03/17/2005WO2005023183A2 Nitrosated ad nitrosylated diuretic compouds, compositions and methods of use
03/17/2005WO2005023182A2 Nitrosated and nitrosylated cardiovascular compounds, compositions and methods of use
03/17/2005WO2005003087A3 Oxazole derivatives as antibacterial agents
03/17/2005WO2004110418A3 Carbonyl compounds as inhibitors of histone deacetylase for the treatment of disease
03/17/2005WO2004074270B1 Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatments using the same
03/17/2005WO2003053959A8 Heterocyclylamino carbonyluracils
03/17/2005WO2003045918A8 Piperidine-based mch antagonists for treatment of obesity and cns disorders
03/17/2005WO2003037887A8 Therapeutic isoquinoline compounds
03/17/2005US20050059726 For treating thrombosis and factor xa-related cardiovascular and neurodegenerative diseases; 6-Chloro-N-{(3S)-1-[3-fluoro-2'-(methylsulfonyl)-1,1'-biphenyl-4-yl]-2-oxopyrrolidin-3-yl}naphthalene-2-sulfonamide for example
03/17/2005US20050059712 Immunosuppressants for treating skin disorders, acne, alopecia, estrogen- or androgen-dependent tumors, rheumatoid arthritis, type I and II diabetes, lupus erythematosus, multiple sclerosis, ulcerative colitis, Crohn's disease, psoriasis, contact dermatitis, graft versus host disease, eczema, asthma
03/17/2005US20050059708 Chemical intermediates of pioglitazone, rosiglitazone and troglitazone; starting inexpensive material, especially tyrosine; hypoglycemic agents, antidiabetic agent, antilipemic agents
03/17/2005US20050059702 Elevate the progenitor and/or stem cell population in peripheral blood or bone marrow; treatment of HIV, inflammatory condition like rheumatoid arthritis, tumor, asthma; 4-(3,3''-Dimethyl-3',4',5',6'-tetrahydro-2'H-cis-[2,2';6',2'']terpyridin-1'-yl-butylamine
03/17/2005US20050059699 N-acylated lipophilic amino acid derivatives
03/17/2005US20050059693 Heterocyclic thioester and ketone hair growth compositions and uses
03/17/2005US20050059687 Modulators of ATP-Binding Cassette transporters
03/17/2005US20050059680 Crystalline ziprasidone HCI and processes for preparation thereof
03/17/2005US20050059678 such as (E)-N-{4-[4-(benzyloxy)-3-chloroanilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-butenamide used as antineoplastic agents, or inhibitors of the HER-2 gene or proteins and epidermal growth factor receptor enzymes
03/17/2005US20050059676 Cyclic pyrazinoylguanidine sodium channel blockers
03/17/2005US20050059671 Hydroxyiminopiperazine compound for therapy and prophylaxis of Urinary incontinence, Inflammatory-bowel disease, addictive disorder, Parkinson's disease, parkinsonism, anxiety, epilepsy, stroke, a seizure, a pruritic condition, psychosis, a cognitive disorder
03/17/2005US20050059666 CCR5 antagonists useful for treating AIDS
03/17/2005US20050059663 4-{3-[4-(6-Chlorobenzothiazol-2-yl)-1,4-diazepan-1-ylcarbonyl]benzyl}-1(2H)-phthalazinone; Cancer, BRCA deficient
03/17/2005US20050059662 Substituted quinazolinone compounds
03/17/2005US20050059658 N-(2,4-Difluorophenyl)-N'-[3-(4,4-dimethyl-6-oxo-1,4,5,6-tetrahydro-3-pyridazinyl)-phenyl]urea and intermediates; antiviral
03/17/2005US20050059657 Aminoisoxazole derivatives active as kinase inhibitors
03/17/2005US20050059655 Nitrosated and nitrosylated diuretic compounds, compositions and methods of use
03/17/2005US20050059607 Process for preparing peptidyl heterocyclic ketone derivatives
03/17/2005US20050058920 Organophotoreceptor with charge transport compound with an azine group
03/17/2005US20050058916 Linked dihydrazone-based charge transport compounds
03/17/2005DE10337942A1 Aminobenzimidazolderivate Aminobenzimidazolderivate
03/17/2005CA2537883A1 Substituted bicyclic quinazolin-4-ylamine derivatives
03/17/2005CA2537098A1 N3 alkylated benzimidazole derivatives as mek inhibitors
03/17/2005CA2536975A1 Nitrosated and nitrosylated diuretic compounds, compositions and methods of use
03/17/2005CA2536967A1 Nitrosated and nitrosylated cardiovascular compounds, compositions and methods of use
03/16/2005EP1514871A1 Dispiro 1,2,4 - trioxolane antimalarials
03/16/2005EP1513837A1 Thiazole derivatives as phosphodiesterase iv inhibitors
03/16/2005EP1513836A1 Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof
03/16/2005EP1513835A1 Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof
03/16/2005EP1513829A2 Nicotinoyl derivatives as herbicidal compounds
03/16/2005EP1513818A2 Heterocyclic inhibitors of kinases
03/16/2005EP1513817A1 1, 2-azole derivatives with hypoglycemic and hypolipidemic activity
03/16/2005EP1513814A1 Novel piperidine compound
03/16/2005EP1513812A1 Substituted indoles
03/16/2005EP1513796A2 Phenyloxyalkanoic acid derivatives as hppar activators
03/16/2005EP1513520A2 Substituted pyrrolines as kinase inhibitors
03/16/2005EP1399436B1 Oxytocin agonists
03/16/2005EP1355903B1 Pyrazole derivatives against tgf overexpression
03/16/2005EP1043319B1 Novel alkylamino derivatives
03/16/2005EP0758324B1 Substituted aromatic thiocarboxylic acid amides and their use as herbicides
03/16/2005CN1596251A Piperazine derivatives having SST1 antagonistic activity
03/16/2005CN1596112A Benzothiazole derivatives
03/16/2005CN1594299A Dibenzo-isozaolone compounds and their synthesis process and application
03/16/2005CN1193027C Substituted pyrroles
03/16/2005CN1193026C Z-pyrazoline-5-ones
03/16/2005CN1193024C Process for producing optically active sulfoxide devivative'
03/15/2005US6867333 Epothilone synthesis building blocks iii and iv: asymmetrically substituted acyloins and acyloin derivatives, methods for their production and methods for the production of epothilones b, d and epothilone derivatives
03/15/2005US6867305 For cancer therapy
03/15/2005US6867299 Inosine monophosphate dehydrogenase (IMPDH); use as immunosuppressants, anticancer agents and antiviral agents
03/15/2005US6867225 Alpha type human peroxisome proliferator activated receptor agonists; such as 2-methyl-2-(3-methyl-4-(((4-phenoxymethyl-2-(4-trifluoromethylphenyl) -thiazol-5-yl-carbonyl)-amino)-methyl)phenoxy)propionic acid
03/15/2005US6867224 Thiazole or oxazole derivatives such as 5-(4-Methyl-2-(4-trifluoromethyl-phenyl)-thiazol-5-ylmethylsulfanyl)-indan-2-carboxylic acid
03/15/2005US6867217 Substituted polycyclic aryl and heteroaryl pyridones useful for selective inhibition of the coagulation cascade
03/15/2005US6867207 IL-5 inhibiting 6-azauracil derivatives
03/15/2005US6867206 6-carboxyphenyldihydropyridazinone derivatives and use thereof
03/15/2005US6867204 Benzoxazine derivatives and uses thereof
03/15/2005US6867201 For therapy of abnormal cell growth, such as cancer, in mammals
03/15/2005US6867200 Anticancer agents; anticoagulants
03/15/2005CA2063671C Aminoguanidines
03/10/2005WO2005021543A1 Phosphoric acid salt of 5-[[4-[2-(5-ethyl-2-pyridinyl) ethoxy] phenyl] methyl]-2, 4-thiazolidinedione
03/10/2005WO2005021542A2 Process for the preparation of pioglitazone
03/10/2005WO2005021541A2 Process for the production of polymorphs of rosiglitazone maleate
03/10/2005WO2005021540A1 Chroman carboxylic acid derivatives for the treatment of diabetes and lipid disorders
03/10/2005WO2005021536A2 Adamantane and azabicyclo-octane and nonane derivatives, process of their preparation and their use as dpp-iv inhibitors
03/10/2005WO2005021531A1 N-substituted benzimidazolyl c-kit inhibitors
03/10/2005WO2005021529A1 Bipyridyl amines and ethers as modulators of metabotropic glutamate receptor-5
03/10/2005WO2005021528A1 2-substituted benzimidazole derivatives as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders
03/10/2005WO2005021519A2 5-phenyl-4-methyl-thiazol-2-yl-amine derivatives as inhibitors of phosphatidylinositol 3 kinase enzymes (pi3) for the treatment of inflammatory airway diseases
03/10/2005WO2005021509A1 Quinoline derivatives as neutrophil elastase inhibitors and their use
03/10/2005WO2005021508A1 Phenyl or pyridyl amide compounds as prostaglandin e2 antagonists
03/10/2005WO2005021500A1 Cyclic derivatives as modulators of chemokine receptor activity
03/10/2005WO2005020990A1 Antibiotic thiazolidines
03/10/2005WO2005020913A2 Formulations, conjugates, and combinations of drugs for the treatment of neoplasms
03/10/2005WO2005020897A2 Compositions and methods for the treatment of disease associated with trp-p8 expression
03/10/2005WO2004112793B1 Guanidino-substituted quinazolinone compounds as mc4-r agonists
03/10/2005WO2004071447B1 Substituted azole derivatives as therapeutic agents
03/10/2005WO2004041794A8 Antiinflammatory 3-arylthio-3-thiazolyl-alkylamines
03/10/2005US20050054819 Such as 1-benzylcyclobutyl (1S)-1-(oxo{[(1R)-1-phenylethyl]amino}acetyl)pentylcarbamate for treatment of osteoporosis
03/10/2005US20050054715 Vinyl phenyl derivatives as glk activators
03/10/2005US20050054712 Dihydroindol-2-one derivatives as steroid hormone nuclear receptor modulators
03/10/2005US20050054697 useful for the treatment or prophylaxis of bacterial infections in mammals
03/10/2005US20050054684 Pioglitazone salts, such as pioglitazone sulfate, and pharmaceutical compositions and processes using the same
03/10/2005US20050054683 Microbiocides; bacteriocides; oxazolidinone compound
1 ... 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 ... 628